Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
2.
Braz. J. Psychiatry (São Paulo, 1999, Impr.) ; 35(2): 157-160, April-June 2013. tab
Article in English | LILACS | ID: lil-680895

ABSTRACT

Objective: To evaluate serum levels of different biomarkers associated with cardiovascular disease in patients with bipolar disorder (BD). Patients were prospectively evaluated in two separate instances: during acute mania and after remission of manic symptoms. All measurements were compared with those of healthy controls. Methods: The study included 30 patients with BD and 30 healthy controls, matched for gender and age. Biochemical parameters evaluated included homocysteine (Hcy), folic acid, vitamin B12, ferritin, creatine kinase (CK) and C-reactive protein (CRP). Results: Hcy levels were significantly higher in the BD patients, both during mania and after achieving euthymia. When Hcy was adjusted for body mass index, there was no significant difference between patients and controls. Ferritin was the only marker that showed a significant decrease during mania when compared to both euthymic patients and controls. There were no significant differences for folate, vitamin B12, CK and CRP. Conclusions: These findings do not show an association between alterations of markers of cardiovascular risk during manic episodes. Further studies are necessary to determine factors and mechanisms associated with cardiovascular risk in patients with BD. .


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Bipolar Disorder/blood , Cardiovascular Diseases/blood , Homocysteine/blood , Biomarkers/blood , Bipolar Disorder/physiopathology , Bipolar Disorder/psychology , Body Mass Index , C-Reactive Protein/analysis , Cardiovascular Diseases/physiopathology , Case-Control Studies , Creatine Kinase/blood , Ferritins/blood , Folic Acid/blood , Prospective Studies , Risk Factors , /blood
3.
Braz. J. Psychiatry (São Paulo, 1999, Impr.) ; 31(2): 136-140, jun. 2009. tab
Article in English | LILACS | ID: lil-517915

ABSTRACT

OBJECTIVE: In the present study, we investigate the association between the val66met polymorphism of the brain-derived neurotrophic factor (BNDF) and the performance on the Wisconsin Card Sorting Test in a sample of Caucasian Brazilian patients with bipolar disorder. METHOD: Sixty-four patients with bipolar disorder were assessed and their performance on the Wisconsin Card Sorting Test was compared with the allele frequency and genotype of the val66met polymorphism of the brain-derived neurotrophic factor. RESULTS: The percentage of non-perseverative errors was significantly higher among patients with the val/val genotype. There was no association between (BNDF) genotype frequency and other Wisconsin Card Sorting Test domains. CONCLUSION: Our results did not replicate previous descriptions of an association between a worse cognitive performance and the presence of the met allele of the val66met brain-derived neurotrophic factor gene polymorphism.


OBJETIVO: O presente estudo tem por objetivo investigar a associação entre o polimorfismo val66met do gene do fator neurotrófico derivado do cérebro (BDNF) e o desempenho cognitivo no Teste Wisconsin de Classificação de Cartas em uma amostra de pacientes bipolares brasileiros caucasianos. MÉTODO: Sessenta e quatro pacientes com transtorno bipolar foram avaliados em relação a sua cognição por meio do Teste Wisconsin de Classificação de Cartas que foi comparada com a freqüência alélica e genotípica do polimorfismo val66met do gene do fator neurotrófico derivado do cérebro. RESULTADOS: O percentual de erros não-perseverativos foi significativamente maior nos indivíduos com genótipo val/val. Não foi encontrada diferença significativa entre a freqüência genotípica do polimorfismo do BDNF e os outros domínios do Teste Wisconsin de Classificação de Cartas. CONCLUSÃO: O estudo do polimorfismo val66met em relação ao desempenho executivo em pacientes bipolares caucasianos de uma amostra brasileira não reproduziu achados anteriores que sugeriam um pior desempenho em indivíduos portadores do alelo met.


Subject(s)
Adult , Female , Humans , Male , Bipolar Disorder/genetics , Brain-Derived Neurotrophic Factor/genetics , Cognition Disorders/genetics , Polymorphism, Single Nucleotide/genetics , Bipolar Disorder/psychology , Brazil/epidemiology , Cognition Disorders/psychology , White People/genetics , Gene Frequency , Genotype , Neuropsychological Tests , Phenotype
SELECTION OF CITATIONS
SEARCH DETAIL